509 related articles for article (PubMed ID: 15302102)
1. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
2. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
[TBL] [Abstract][Full Text] [Related]
3. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
6. Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial.
Patten M; Maas R; Karim A; Müller HW; Simonovsky R; Meinertz T
J Cardiovasc Electrophysiol; 2006 Nov; 17(11):1216-20. PubMed ID: 16987384
[TBL] [Abstract][Full Text] [Related]
7. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
[TBL] [Abstract][Full Text] [Related]
8. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
[TBL] [Abstract][Full Text] [Related]
9. [PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].
Nitschmann S; Antz M; Kuck KH
Internist (Berl); 2005 Jul; 46(7):800-2. PubMed ID: 15947902
[No Abstract] [Full Text] [Related]
10. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
Bianconi L; Calò L; Mennuni M; Santini L; Morosetti P; Azzolini P; Barbato G; Biscione F; Romano P; Santini M
Europace; 2011 Feb; 13(2):174-81. PubMed ID: 21059740
[TBL] [Abstract][Full Text] [Related]
11. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
Trappe HJ; Pfitzner P
Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone versus sotalol for atrial fibrillation.
Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
[TBL] [Abstract][Full Text] [Related]
17. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
[TBL] [Abstract][Full Text] [Related]
18. Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.
Lombardi F; Borggrefe M; Ruzyllo W; Lüderitz B;
Eur Heart J; 2006 Sep; 27(18):2224-31. PubMed ID: 16935870
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
[TBL] [Abstract][Full Text] [Related]
20. Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery.
Scherer M; Dzemali O; Aybek T; Wimmer-Greinecker G; Moritz A
J Heart Valve Dis; 2003 Jul; 12(4):469-74. PubMed ID: 12918849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
